| Date Filed | Type | Description |
| 08/09/2023 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Disposed/sold 8,427 shares
@ $0
Disposed/sold 4,357 options to buy
@ $17, valued at
$74.1k
Disposed/sold 9,138 options to buy
@ $17, valued at
$155.3k
Disposed/sold 8,261 options to buy
@ $17, valued at
$140.4k
Disposed/sold 22,600 options to buy
@ $17, valued at
$384.2k
Disposed/sold 31,250 options to buy
@ $14.98, valued at
$468.1k
|
|
| 05/09/2023 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Sold 84,097 shares
@ $38.5056, valued at
$3.2M
|
|
| 02/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,106 shares
@ $9.64, valued at
$10.7k
Exercised 3,196 restricted stock units
@ $0 |
|
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2022 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Granted 14,633 shares
@ $0 |
|
| 08/29/2022 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Granted 57,755 shares
@ $0 |
|
| 08/18/2022 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,101 shares
@ $11.08, valued at
$12.2k
Exercised 3,196 restricted stock units
@ $0 |
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Granted 31,250 options to buy
@ $14.98, valued at
$468.1k
|
|
| 05/18/2022 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Paid exercise price by delivering 1,310 shares
@ $6.74, valued at
$8.8k
Exercised 3,195 restricted stock units
@ $0 |
|
| 03/15/2022 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 25,566 restricted stock units
@ $0 |
|
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2021 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on DICE Therapeutics, Inc.|
Txns:
| Granted 4,357 options to buy
@ $17, valued at
$74.1k
Granted 9,138 options to buy
@ $17, valued at
$155.3k
Granted 8,261 options to buy
@ $17, valued at
$140.4k
Granted 8,500 options to buy
@ $17, valued at
$144.5k
Granted 5,600 options to buy
@ $17, valued at
$95.2k
|
|
| 09/16/2021 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Granted 18,421 shares
@ $0 |
|
| 09/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/09/2021 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on Alector, Inc.|
Txns:
| Sold 9,981 shares
@ $31.14, valued at
$310.8k
Sold 52,868 shares
@ $27.6413, valued at
$1.5M
Sold 3,392 shares
@ $28.3022, valued at
$96k
Exercised 56,260 options to buy
@ $10.14, valued at
$570.5k
|
|
| 08/06/2021 |
4
| SCHELLER RICHARD H (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 13,777 shares
@ $53.2276, valued at
$733.3k
Exercised 13,777 options to buy
@ $17, valued at
$234.2k
|
|
| 06/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2020 |
4
| SCHELLER RICHARD H (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 14,928 shares
@ $64.8069, valued at
$967.4k
Sold 45,473 shares
@ $65.4828, valued at
$3M
|
|
| 12/21/2020 |
4
| SCHELLER RICHARD H (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 27,105 shares
@ $64.9913, valued at
$1.8M
Sold 2,895 shares
@ $65.7795, valued at
$190.4k
|
|
| 12/17/2020 |
4
| SCHELLER RICHARD H (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 12,091 shares
@ $59.806, valued at
$723.1k
Sold 19,352 shares
@ $60.7329, valued at
$1.2M
Exercised 29,277 options to buy
@ $17, valued at
$497.7k
|
|
| 09/18/2020 |
4
| SCHELLER RICHARD H (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Sold 25,000 shares
@ $37.5, valued at
$937.5k
|
|
| 06/04/2020 |
4
| SCHELLER RICHARD H (See Remarks) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 112,422 options to buy
@ $29, valued at
$3.3M
|
|
| 05/13/2020 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on Alector, Inc.|
Txns:
| Granted 19,274 options to buy
@ $29.09, valued at
$560.7k
|
|
| 04/28/2020 |
4
| SCHELLER RICHARD H (Director) has filed a Form 4 on Oric Pharmaceuticals, Inc.|
Txns:
| Converted 25,000 shares
@ $0
Converted 25,000 preferred shares
@ $0 |
|
|